ALPHA PSYCHIATRY
Original Articles

Methylphenidate induced gynecomastia in a prepubertal boy: a case report

1.

M.D. Adiyaman University, School of Medicine, Department of Psychiatry, Adiyaman, Turkey

2.

Assist.Prof. Adiyaman University, School of Medicine, Department of Pediatrics, Adiyaman, Turkey

3.

Assist.Prof. Adiyaman University, School of Medicine, Department of Psychiatry, Adiyaman, Turkey

4.

M.D. Adiyaman University, School of Medicine, Department of Child Psychiatry, Adiyaman, Turkey

5.

Prof. Adiyaman University, School of Medicine, Department of Pediatrics, Adiyaman, Turkey

Alpha Psychiatry 2016; 17: Supplement 74-76
DOI: 10.5455/apd.177010
Read: 1158 Downloads: 531 Published: 01 June 2016

Methylphenidate is a frequently used treatment choice in attention deficit hyperactivity disorder. In this paper we will present a prepubertal boy who suddenly developed bilateral gynecomastia after sustained release methylphenidate (OROS MPH) treatment and we will discuss literature on this topic. Although the mechanism is not known, rare development of gynecomastia should be kept in mind in cases using methylphenidate. [Anadolu Psikiyatri Derg 2016; 17(0.300): 74-76]

Files
EISSN 2757-8038